NCT05296733: A Study to (1) Compare How BI 456906 is Taken up in the Body of Healthy People and People With Liver Problems and (2) Find Out How People With Overweight and Obesity, With and Without Liver Problems, Tolerate Different Doses of BI 456906
- State
- Completed
- Phase
- Phase 1
- People
- 82 taking part
- Started
- 27 Apr 2022
- Primary completion
- 29 Dec 2023
- Arms
- Part A: BI 456906: Cohort 1, Part A: BI 456906: Cohort 2, Part A: BI 456906: Cohort 3, Part A: BI 456906: Cohort 4, Part B: BI456906: Cohort 1, Part B: BI456906: Cohort 2, Part B: BI456906: Cohort 3
- Results
- None posted
- Papers
- doi:10.1016/j.jhep.2024.06.003
- 25 Mar 2022: Trial registered
- 27 Apr 2022: Trial started
- 29 Dec 2023: Trial completed